Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Integrin alpha-IIb/beta-3' and Ligand = 'BDBM228626'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM228626 (US9345793, 7 | US9744252, Example 7) Show SMILES OC(=O)C[C@H](NC(=O)[C@@H]1CCCN(C1)C(=O)CCC1CCNCC1)c1cncc(c1)-c1ccc(OCCF)cc1 |r| Show InChI InChI=1S/C30H39FN4O5/c31-11-15-40-26-6-4-22(5-7-26)24-16-25(19-33-18-24)27(17-29(37)38)34-30(39)23-2-1-14-35(20-23)28(36)8-3-21-9-12-32-13-10-21/h4-7,16,18-19,21,23,27,32H,1-3,8-15,17,20H2,(H,34,39)(H,37,38)/t23-,27+/m1/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	11	n/a	n/a	n/a	n/a	n/a	2
PIRAMAL IMAGING SA US Patent					Assay Description The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...				US Patent US9345793 (2016) BindingDB Entry DOI: 10.7270/Q22806GR
					More data for this Ligand-Target Pair